
Loading, please wait...

Loading, please wait...

Acute ischemic stroke caused by large-vessel occlusion represents a critical medical emergency requiring rapid intervention. Historically, clinicians routinely excluded patients presenting with low Alberta Stroke Program Early CT Scores or baseline functional limitations from interventional therapy. However, emerging evidence regarding prestroke disability EVT outcomes is reshaping neurointerventional decision-making. Physicians often struggle when deciding whether to treat patients who already possess baseline functional impairments and extensive early ischemic changes. A major multicenter study published in the Journal of Neurosurgery provides crucial clarity on whether premorbid status should disqualify individuals from mechanical revascularization.
The multicenter investigation analyzed retrospective data gathered across thirty-two international comprehensive stroke centers between January 2013 and December 2022. Researchers focused specifically on acute ischemic stroke patients with large-vessel occlusions presenting with low Alberta Stroke Program Early CT Scores, defined as values between two and five. Furthermore, the study defined prestroke disability as a baseline modified Rankin Scale score of two or greater. Among two hundred ninety-three enrolled patients, fifty individuals, or approximately seventeen percent, exhibited documented prestroke disability before their acute index event. Within this disabled cohort, forty percent had baseline modified Rankin Scale scores of two, forty-eight percent had scores of three, and twelve percent had scores of four. The investigators evaluated whether these pre-existing deficits compromised the primary goal of endovascular therapy, which was achieving a return to baseline functional status at ninety days. By concentrating on this challenging demographic, the study addresses a persistent clinical dilemma in acute stroke triage. Consequently, these findings offer valuable real-world evidence for interventional teams confronting complex candidates.
When assessing functional outcomes, the primary endpoint demonstrated no statistically significant difference between individuals with baseline disability and those without prior impairment. Specifically, patients with prestroke disability achieved a return to their premorbid functional baseline at rates comparable to previously independent patients. Nevertheless, secondary outcome analyses revealed nuanced differences between the cohorts. Patients with baseline functional limitations exhibited a significantly smaller proportion of achieving independent ambulation, defined as modified Rankin Scale scores of zero to three, or returning to baseline status, yielding an adjusted odds ratio of 0.13. Similarly, achieving a traditional good functional outcome, represented by scores of zero to two or return to baseline, occurred less frequently in the disabled cohort, with an adjusted odds ratio of 0.21. These statistical findings reflect the physiological constraints imposed by pre-existing neurological or systemic deficits. However, the preservation of baseline function remains a meaningful therapeutic achievement for these vulnerable individuals. Therefore, evaluating recovery against an individual's personal baseline status provides a far more appropriate measure of therapeutic success than applying rigid, universal functional thresholds.
Safety considerations represent a paramount concern when offering mechanical thrombectomy to patients with extensive ischemic core volumes and pre-existing disabilities. Clinicians frequently worry that extensive tissue injury increases the likelihood of catastrophic hemorrhagic transformation following successful reperfusion. Reassuringly, the study demonstrated no significant difference in safety outcomes between patients with prestroke disability and those who were previously independent. The rates of overall intracranial hemorrhage and symptomatic intracranial hemorrhage remained statistically indistinguishable across both groups. Symptomatic intracranial hemorrhage, strictly defined as post-procedural bleeding accompanied by a worsening of four or more points on the National Institutes of Health Stroke Scale, did not show an elevated frequency in disabled patients. Additionally, successful recanalization rates and overall ninety-day mortality demonstrated comparable distributions between the two study populations. These findings indicate that pre-existing functional dependency does not intrinsically augment procedural vulnerability or heighten hemorrhagic complications. Consequently, interventionalists can proceed with revascularization without fearing disproportionately elevated safety risks in this vulnerable patient population.
For decades, clinical stroke trials established strict exclusion criteria that systematically barred individuals with baseline disability and low initial imaging scores. These exclusion policies inadvertently fostered clinical nihilism regarding older, dependent, or multimorbid stroke candidates. However, contemporary randomized trials and observational cohorts continue to challenge these historic paradigms. The current study clearly underscores that baseline disability should not serve as an absolute barrier to mechanical revascularization. When acute large-vessel occlusion strikes a functionally impaired patient, successful vessel recanalization can prevent devastating complete loss of autonomy. For example, maintaining the ability to communicate, eat independently, or assist with transfers represents a vital clinical victory that significantly impacts patient dignity and caregiver burden. Therefore, clinicians must avoid excluding candidates with low imaging scores solely due to pre-existing disability. Instead, treating teams should engage in nuanced clinical assessments, weighing ischemic core progression, collateral circulation, vascular anatomy, and overall goals of care before declining intervention.
Integrating these findings into real-world acute stroke networks demands coordinated workflows across emergency medical teams, diagnostic neuroradiology, and post-acute rehabilitation. Early emergency department identification and advanced neuroimaging interpretation allow rapid identification of salvageable tissue, regardless of premorbid functional scores. Following revascularization, aggressive multidisciplinary neurocritical care and personalized rehabilitation play indispensable roles in maximizing functional recovery. Critical care teams must optimize hemodynamics, glycemic control, and secondary complication prevention to protect vulnerable penumbral zones. Furthermore, physical and occupational therapists should tailor restorative goals to help patients regain their prior baseline mobility rather than pursuing unrealistic complete independence. Clear communication with surrogate decision-makers regarding realistic recovery trajectories remains equally vital throughout the hospitalization. By adopting a comprehensive, patient-centered approach, healthcare systems can ensure equitable access to life-altering therapies while optimizing long-term post-stroke management for all patient groups.
In summary, clinical evidence confirms that mechanical thrombectomy offers meaningful clinical benefits to properly selected acute stroke patients with large core infarctions and pre-existing disability. Revascularization achieves comparable safety profiles and preserves baseline functional capacity without elevating symptomatic bleeding risks. Therefore, stroke teams should adopt updated protocols that encourage individualized evaluations rather than categorical exclusions. First, neurointerventionalists should confirm large-vessel occlusion and assess tissue viability using established imaging protocols. Second, clinicians should evaluate pre-stroke functional status accurately to establish personalized therapeutic goals. Third, treatment decisions should balance procedural feasibility against individual patient values and family expectations. Ultimately, withholding mechanical thrombectomy based solely on pre-existing physical limitations is no longer scientifically justified. As evidence continues to expand, acute stroke management must embrace inclusive, evidence-based practices that prioritize meaningful functional preservation for every patient.
Prestroke disability is typically defined using the modified Rankin Scale, with a score of two or greater representing pre-existing functional impairment. A score of two denotes slight disability where patients manage their own affairs without assistance, while higher scores reflect progressively greater dependency in daily activities.
No, recent multicenter evidence indicates that baseline functional disability does not significantly increase the risk of symptomatic intracranial hemorrhage. Rates of post-procedural hemorrhagic transformation and ninety-day mortality remain comparable between patients with pre-existing disability and those who were independent before the stroke event.
Mechanical thrombectomy helps prevent catastrophic clinical worsening and promotes a return to baseline functional capacity. Even for patients with prior disability, successful revascularization preserves essential functional abilities like self-care or assisted transfers, which substantially improves quality of life and reduces long-term caregiver burden.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. Clinical decisions should always be made by qualified healthcare professionals based on individual patient assessment and clinical judgment. Refer to the latest local and national guidelines for clinical practice.
References
1. Matsukawa H et al. The influence of prestroke disability on outcome in patients with a low Alberta Stroke Program Early CT Score who underwent endovascular thrombectomy. J Neurosurg. 2025 Jul 01. doi: 10.3171/2024.10.JNS24888. PMID: 39919282.
2. De Havenon A, Castonguay A, Nogueira R, et al. Prestroke Disability and Outcome After Thrombectomy for Emergent Anterior Circulation Large Vessel Occlusion Stroke. Neurology. 2021;97(19):e1914-e1920.
3. Sarraj A, Hassan AE, Abraham MG, et al. Endovascular Thrombectomy for Acute Ischemic Stroke with Large Ischemic Core: A Review and Meta-analysis. JAMA Neurol. 2023;80(5):453-463.
4. Alawieh A, Starke RM, Chatterjee R, et al. Impact of Successful Reperfusion on Functional Outcomes After Thrombectomy in Patients with Pre-stroke Disability. J Neurointerv Surg. 2024;16(8):780-786.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A 32-center study reveals that prestroke disability does not reduce the likelihood of returning to baseline function or increase hemorrhage risks in low ASPECTS stroke patients undergoing EVT, supporting more inclusive patient selection.
Today

A comprehensive study explores the substantial impact of perceived stigma on medication adherence and healthcare perception among patients with inflammatory bowel disease, highlighting key clinical strategies to mitigate stigma and improve long-term outcomes.
Today

OmniActive has introduced Fenavari in India, a standardized botanical nutraceutical combining fenugreek and shatavari. Clinical trials show over 50% reduction in vasomotor symptoms, improved estradiol levels, and reduced FSH, presenting a non-hormonal option for perimenopausal and postmenopausal care.
Today

A contemporary UK study evaluates the link between dental exposure and oral flora infective endocarditis using transoesophageal echocardiography. We review key findings on valvular patterns, pathogen profiles, and antibiotic prophylaxis considerations.
Today

Spinal cord tissue engineering scaffolds represent a transformative therapeutic strategy for spinal cord injury repair, bridging anatomical gaps and delivering cellular and biochemical therapies to restore neural circuitry.
Today

Fibroblast growth factor (FGF) and FGFR signaling pathways govern critical physiological processes. This review highlights their molecular mechanisms, roles in skeletal dysplasia and oncology, and emerging targeted therapeutic strategies.
Today